abstract |
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): n n n n n n n n n n n n wherein x, y, W, V, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 7a , R 8 , R 8a , R 9 , R 9a , R 10 and R 10a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed. |